Related Funds
Fund Name | Location |
AGPS Tech Limited | China, Hong Kong, Hong Kong Island |
Alliance Global Partners | New York, New York, United States |
Aviv Venture Capital | HaMerkaz, Israel, Petah Tiqva |
Axa and main incubator | - |
Bootleg Advisors | - |
Brand Ventures | Cincinnati, Ohio, United States |
Chengpu Touzi | Beijing, Beijing, China |
China South Publishing & Media Group | Changsha, China, Jiangsu |
Chongrong Investment | Beijing, China, Fangshan |
Ewing Irrigation & Landscape Supply | Arizona, Phoenix, United States |
Impact Hub Milan | Italy, Lombardia, Milano |
Jiankang 160 | China, Guangdong, Shenzhen |
Jiaxing Xiaoyuan Chuangye Touzi Hehuo Qiye | China, Jiaxing, Zhejiang |
Ningbo Dongshi Advertising | China, Ningbo, Zhejiang |
Safe & Rich Venture Capital | China, Hangzhou, Zhejiang |
Techplace | Burlington, Canada, Ontario |
Trend Forward Capital | California, San Jose, United States |
Wanfeng Jinyuan Holding Group | China, Shanghai |
Zachary Construction | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Outpace Bio | $30M | 31 Mar 2021 | Seattle, Washington, United States | ||
Sonoma Pharmaceuticals | $70M | 30 Sep 2020 | California, United States | ||
Cero Therapeutics | $40M | 18 Mar 2020 | South San Francisco, California, United States | ||
Sonoma BioTherapeutics | $40M | 06 Feb 2020 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Outpace Bio | $30M | 31 Mar 2021 | Seattle, Washington, United States | ||
Sonoma Pharmaceuticals | $70M | 30 Sep 2020 | California, United States | ||
Cero Therapeutics | $40M | 18 Mar 2020 | South San Francisco, California, United States | ||
Sonoma BioTherapeutics | $40M | 06 Feb 2020 | South San Francisco, California, United States |